Summary
- Profile Type
- Business Offer
- POD Reference
- BOTR20240924007
- Term of Validity
- 9 December 2024 - 9 December 2025
- Company's Country
- Turkey
- Type of partnership
- Commercial agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- A biotechnology firm in Kayseri, the centre of Anatolia, utilizes AI-driven technologies to provide personalized health solutions through gut microbiota analysis, offering tailored dietary and probiotic recommendations. The firm seeks commercial partners to expand its integrated biotechnology solutions and health services ecosystem.
- Full Description
-
Established in 2019 and located in Kayseri, this biotechnology enterprise focuses on enhancing human health through research and development in microbiome science. The company utilizes microbiome organisms to create products and services to improve health quality and promote optimal gut health.
The company offers AI-powered microbiome analysis, which begins with clients receiving a sample collection kit at home. After collecting their sample, clients send it back at no charge. The sample undergoes DNA analysis in certified laboratories, where advanced AI software processes the data to identify gut bacteria and their ecological relationships. Based on the results of the analysis, personalized dietary recommendations and tailored food suggestions are provided to promote a healthier microbiome. Additionally, the company offers customized probiotic and prebiotic solutions that align with each individual's microbiome profile, ensuring effective supplementation. Clients can access their analysis reports and dietary insights through a connected mobile app.
The company is seeking commercial partners to collaborate on distributing integrated biotechnology products and health solutions. They aim to expand distribution channels by working with distributors, retailers, and e-commerce platforms to enhance product availability and reach a wider audience. - Advantages and Innovations
- The company provides personalized health solutions through AI-driven microbiome analysis, offering tailored dietary and supplement recommendations. Its user-friendly sample collection and mobile app enhance client engagement, while comprehensive DNA analysis delivers insights into gut health. By partnering with distributors and retailers, the company expands product availability, ensuring continuous innovation in health solutions.
- Stage of Development
- Already on the market
- Sustainable Development Goals
- Goal 5: Gender Equality
- Goal 3: Good Health and Well-being
- Goal 17: Partnerships to achieve the Goal
- IPR status
- No IPR applied
Partner Sought
- Expected Role of a Partner
-
- Collaborating to promote and distribute the company's products across various channels, including retail, e-commerce, and health services.
- Expanding the company's reach into new markets and customer segments, leveraging local market knowledge and networks.
- Providing valuable customer feedback to help improve products and services, ensuring they meet market demands. - Type and Size of Partner
- SME 11-49
- University
- Big company
- SME <=10
- SME 50 - 249
- Other
- R&D Institution
- Type of partnership
- Commercial agreement
Dissemination
- Technology keywords
- 01004001 - Applications for Health
- 06005003 - Health information management
- Market keywords
- 05007007 - Other medical/health related (not elsewhere classified)
- 02007012 - Medical/health software
- Sector Groups Involved
- Digital
- Health
- Targeted countries
- All countries